Thursday, December 8, 2022
wellness India Expo
Home Tags Omicron

Tag: Omicron

Moderna seeks US-FDA approval for emergency use of BA.4/BA.5 Omicron booster

Subject to the regulatory approval, Moderna is ready to ship bivalent booster mRNA-1273.222 in September

The Gamaleya Center develops Delta & Omicron-adapted Sputnik V vaccine

The Delta and Omicron-adapted version of Sputnik V is the most promising version of the vaccine specifically adapted to new variants as compared to those tailored against the combination of the original strain and Omicron variant

ICAR launches Covid-19 vaccine for animals

The Ancovax Vaccine on Equines, an inactivated SARS-CoV-2 Delta (COVID-19) vaccine for animals neutralizes both Delta and Omicron variants

Delta variant might return back, warn Israeli researchers

While Delta wiped out the variants that preceded it, Omicron has not eliminated Delta

Mathematical model to predict COVID-19 vaccine efficacy

The researchers began by analysing over 80 different neutralising antibodies reported to be generated after vaccination against the surface spike protein of SARS-CoV-2, the virus that causes COVID-19

Delta & Omicron may both co-circulate: Experts

While Delta has two mutations on the receptor-binding domain of the spike protein, Omicron has 15. This has resulted in evasion from antibody binding, necessary for protection.

COVAXIN (BBV152) booster shown to neutralize both Omicron & Delta variants...

100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization of the Omicron variant

IHME forecasts enormous spread of Omicron

The analysis by IHME shows that increasing mask use to 80% will have a huge effect on cases, hospitalizations, and deaths

Tata MD launches COVID Express RT-PCR testing solutions to boost Omicron...

Indigenously developed RT-PCR test for economical, variant-proof, and express use

Thermo Fisher Scientific claims its TaqPath COVID-19 tests can detect Omicron...

The TaqPath COVID-19 assays detect SARS-CoV-2 infections by identifying the presence of three gene targets from the orf1a/b, S, and N regions of the virus